[go: up one dir, main page]

AP2000001787A0 - Use of thiazolidinediones for the treatment of hyperglycaemia. - Google Patents

Use of thiazolidinediones for the treatment of hyperglycaemia.

Info

Publication number
AP2000001787A0
AP2000001787A0 APAP/P/2000/001787A AP2000001787A AP2000001787A0 AP 2000001787 A0 AP2000001787 A0 AP 2000001787A0 AP 2000001787 A AP2000001787 A AP 2000001787A AP 2000001787 A0 AP2000001787 A0 AP 2000001787A0
Authority
AP
ARIPO
Prior art keywords
hyperglycaemia
treatment
thiazolidinediones
efective
mammal
Prior art date
Application number
APAP/P/2000/001787A
Other languages
English (en)
Inventor
Robin Edwin Buckingham
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of AP2000001787A0 publication Critical patent/AP2000001787A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
APAP/P/2000/001787A 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia. AP2000001787A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9721693.1A GB9721693D0 (en) 1997-10-13 1997-10-13 Novel treatment
PCT/GB1998/003064 WO1999018943A1 (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia

Publications (1)

Publication Number Publication Date
AP2000001787A0 true AP2000001787A0 (en) 2000-06-30

Family

ID=10820482

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2000/001787A AP2000001787A0 (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia.

Country Status (24)

Country Link
EP (1) EP1023056A1 (ru)
JP (1) JP2001519382A (ru)
KR (1) KR20010024481A (ru)
CN (1) CN1281359A (ru)
AP (1) AP2000001787A0 (ru)
AU (1) AU9547098A (ru)
BG (1) BG104404A (ru)
BR (1) BR9815219A (ru)
CA (1) CA2306086A1 (ru)
CZ (1) CZ20001297A3 (ru)
EA (1) EA002659B1 (ru)
GB (1) GB9721693D0 (ru)
HR (1) HRP20000255A2 (ru)
HU (1) HUP0003922A3 (ru)
ID (1) ID24521A (ru)
IL (1) IL135513A0 (ru)
NO (1) NO20001898L (ru)
NZ (1) NZ503862A (ru)
OA (1) OA11683A (ru)
PL (1) PL339813A1 (ru)
SK (1) SK5312000A3 (ru)
TR (1) TR200000958T2 (ru)
WO (1) WO1999018943A1 (ru)
YU (1) YU28800A (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2137915T3 (es) * 1987-09-04 2000-01-01 Beecham Group Plc Derivados de tiazolidindiona sustituida.
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus

Also Published As

Publication number Publication date
NO20001898D0 (no) 2000-04-12
EA002659B1 (ru) 2002-08-29
PL339813A1 (en) 2001-01-02
IL135513A0 (en) 2001-05-20
ID24521A (id) 2000-07-20
SK5312000A3 (en) 2000-09-12
NZ503862A (en) 2003-01-31
KR20010024481A (ko) 2001-03-26
CZ20001297A3 (cs) 2001-08-15
BG104404A (bg) 2000-12-29
BR9815219A (pt) 2001-01-02
HRP20000255A2 (en) 2001-02-28
CA2306086A1 (en) 1999-04-22
HUP0003922A2 (hu) 2001-10-28
EP1023056A1 (en) 2000-08-02
YU28800A (sh) 2003-02-28
AU9547098A (en) 1999-05-03
EA200000419A1 (ru) 2000-10-30
TR200000958T2 (tr) 2000-08-21
WO1999018943A1 (en) 1999-04-22
JP2001519382A (ja) 2001-10-23
HUP0003922A3 (en) 2001-12-28
CN1281359A (zh) 2001-01-24
GB9721693D0 (en) 1997-12-10
OA11683A (en) 2005-01-12
NO20001898L (no) 2000-06-09

Similar Documents

Publication Publication Date Title
EP1787646A3 (en) Novel method of treatment
MXPA05007470A (es) Metodo para reducir la morbilidad y mortalidad cardiovascular en pacientes prediabeticos y pacientes con diabetes de tipo 2.
WO2000007575A3 (en) Methods and compositions for increasing insulin sensitivity
SG127714A1 (en) Method of treating metabolic disorders, especiallydiabetes, or a disease or condition associated wi th diabetes
MXPA03003870A (es) Terapia de combinacion que comprende agentes antidiabeticos y anticonvulsionantes.
CA2071629A1 (en) Use of insulin sensitizing agents to treat hypertension
AP2001002291A0 (en) Novel method of treatment.
WO2003082260A3 (en) Tuberculosis treatment using pleuromutilin derivatives
MY155219A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and biguanide
HK1047707A1 (zh) (+)-曲馬朵、o-去甲曲馬朵或(+)-o-去甲曲馬朵、o-去甲-n-單-去甲-曲馬朵或(+)-o-去甲-n-單-去甲-曲馬朵治療尿失禁的用途
AU5547501A (en) Method of reducing side effects of chemotherapy in cancer patients
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
AU1720697A (en) Nutrient composition for exercise
AP9901720A0 (en) Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitors.
MY125855A (en) Treatment of diabetes with a thiazolidinedione and sulphonylurea
MY138246A (en) Treatment of diabetes with thiazolidione and sulphonylurea.
AP2000001735A0 (en) Treatment of diabetes with thiazolidinedione insulin secretagogue and alpha glucocidase inhibitor.
AP2000001787A0 (en) Use of thiazolidinediones for the treatment of hyperglycaemia.
CA2234936A1 (en) Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine
TR200101336T2 (tr) Bir-beta-agonisti ile başka bir antidiyabetik madde içeren kombinasyonlar
WO1999064065A3 (en) Tumour therapy and imaging
YU28700A (sh) Upotreba potencijatora osetljivosti na insulin u proizvodnji leka za lečenje hiperglikemije
MX9701606A (es) Terapia de combinacion para evitar la perdida osea-progesterona y agonistas de estrogeno.
AU4937499A (en) Use of succinic acid or salts thereof and method of treating insulin resistance
EP0904094A4 (en) TREATMENT OF BONE DISEASES WITH ADRENOMEDULLIN